Skip to main navigation
Investor Relations
  • Home
  • About Us
    • Our Goal
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • Our Focus
    • The Challenge
    • Platform
  • Focus Areas
    • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filings
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQS
      • Email Alerts
  • Contact Us
Menu
Investor Relations
  • Home
  • About Us
    • Our Goal
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • Our Focus
    • The Challenge
    • Platform
  • Focus Areas
    • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filings
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQS
      • Email Alerts
  • Contact Us

SEC Filing Details

Document Details

Form
S-3
Filing Date
Aug 21, 2026
Document Date
Aug 21, 2026
Form Description
Simplified registration form
Filing Group
Registration Statements
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT
Email Alerts
Investor FAQs
Contact IR
Logo

Hadassah Bio Park, 5th Floor |
Jerusalem Israel 9112002

info@enterabio.com

About Us
Home
About
Technology
Science
News and Events
Investors & Media
Contact Us
Accessibility Statement
Search Site
Search
Footer Bottom Social

Folow Us

  • Facebook
  • Twitter
  • Linkedin
  • Instagram

A-2-Z - Digital Accessibility and Marketing

© 2026 Entera Bio Ltd.

Privacy Policy